Diabetic neuropathy
MONDO:0006626A chronic, pathological complication associated with diabetes mellitus, where nerve damages are incurred due to diabetic microvascular injury involving small blood vessels that supply these nerves, resulting in peripheral and/or autonomic nerve dysfunction.
159 clinical trials for this condition and its sub-types.
Follow this condition — get notified about new trialsSub-types
Broader categories
-
Fish oil fails to deliver in nerve damage trial
Disease control TerminatedThis study tested whether high-dose fish oil supplements could improve nerve function in people with prediabetes and early diabetic neuropathy. Researchers planned to enroll 40 adults aged 55–80, but the trial was terminated early with only 31 participants. Participants took eith…
Phase: NA • Sponsor: University of Missouri-Columbia • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
Vitamin-Like supplement tested for diabetic nerve pain – but trial stopped early
Disease control TerminatedThis early-phase trial tested whether nicotinamide riboside (a form of vitamin B3 sold as Niagen) could help repair nerve damage in people with type 2 diabetes or prediabetes. Only 10 participants were enrolled before the study was terminated. The main goal was to measure changes…
Phase: PHASE1, PHASE2 • Sponsor: University of Maryland, Baltimore • Aim: Disease control
Last updated Jun 27, 2026 08:09 UTC
-
Experimental nerve pain drug trial halted midway
Symptom relief TerminatedThis study tested an experimental drug called RTA 901 to see if it could safely reduce nerve pain in people with diabetes. The trial planned to enroll 209 adults with diabetic peripheral neuropathic pain, comparing two doses of the drug against a placebo over 12 weeks. However, t…
Phase: PHASE2 • Sponsor: Reata, a wholly owned subsidiary of Biogen • Aim: Symptom relief
Last updated Jun 27, 2026 08:04 UTC
-
New drug aimed at easing diabetic nerve pain hits roadblock
Symptom relief TerminatedThis study tested an experimental drug called GSK3858279 in 147 adults with chronic nerve pain from diabetes. The goal was to see if it could reduce pain better than a placebo. However, the trial was terminated early, so we have less information than planned.
Phase: PHASE2 • Sponsor: GlaxoSmithKline • Aim: Symptom relief
Last updated Jun 27, 2026 07:58 UTC
-
Pain relief device for diabetic nerve pain studied, but trial stopped early
Symptom relief TerminatedThis study tested a device called BurstDR spinal cord stimulation to help people with painful diabetic neuropathy that didn't get better with standard medicines. The goal was to see if it could cut leg pain by at least half. Only 6 people joined before the study was stopped early…
Sponsor: Wake Forest University Health Sciences • Aim: Symptom relief
Last updated Jun 27, 2026 07:56 UTC